FHR4-based complement-activating multimeric immunotherapeutic complexes (COMIX) inhibit tumor growth of HER2-expressing xenografts in nude mice

Carole Devaux, Quentin Etienne, Jacques H. M. Cohen, Xavier Dervillez

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Pages	456-457
Publication status	Published - Oct 2019
Event	17th European Meeting on Complement in Human Disease (EMCHD) - Madrid, Spain Duration: 14 Sept 2019 → 17 Sept 2019

Conference

Conference	17th European Meeting on Complement in Human Disease (EMCHD)
Country/Territory	Spain
City	Madrid
Period	14/09/19 → 17/09/19

Access to Document

https://www.sciencedirect.com/journal/molecular-immunology/vol/114/suppl/CLicence: Unspecified

Other files and links

https://www.aminer.org/pub/5fc9ab75d83c7e914a9db928/fhr-based-complement-activating-multimeric-immunotherapeutic-complexes-comix-inhibit-tumor-growth-of

Cite this

Devaux, C., Etienne, Q., Cohen, J. H. M., & Dervillez, X. (2019). FHR4-based complement-activating multimeric immunotherapeutic complexes (COMIX) inhibit tumor growth of HER2-expressing xenografts in nude mice. 456-457. Abstract from 17th European Meeting on Complement in Human Disease (EMCHD), Madrid, Spain. https://www.sciencedirect.com/journal/molecular-immunology/vol/114/suppl/C

@conference{9d573a018d244822b87234fa526bdca5,

title = "FHR4-based complement-activating multimeric immunotherapeutic complexes (COMIX) inhibit tumor growth of HER2-expressing xenografts in nude mice",

author = "Carole Devaux and Quentin Etienne and Cohen, {Jacques H. M.} and Xavier Dervillez",

note = "Molecular Immunology Volume: 114 Issue number: Pages (from-to): 456-457 Article number: 124 ; 17th European Meeting on Complement in Human Disease (EMCHD) ; Conference date: 14-09-2019 Through 17-09-2019",

year = "2019",

month = oct,

language = "English",

pages = "456--457",

}

Devaux, C, Etienne, Q, Cohen, JHM & Dervillez, X 2019, 'FHR4-based complement-activating multimeric immunotherapeutic complexes (COMIX) inhibit tumor growth of HER2-expressing xenografts in nude mice', 17th European Meeting on Complement in Human Disease (EMCHD), Madrid, Spain, 14/09/19 - 17/09/19 pp. 456-457. <https://www.sciencedirect.com/journal/molecular-immunology/vol/114/suppl/C>

FHR4-based complement-activating multimeric immunotherapeutic complexes (COMIX) inhibit tumor growth of HER2-expressing xenografts in nude mice. / Devaux, Carole; Etienne, Quentin; Cohen, Jacques H. M. et al.
2019. 456-457 Abstract from 17th European Meeting on Complement in Human Disease (EMCHD), Madrid, Spain.

Research output: Contribution to conference › Abstract › peer-review

TY - CONF

T1 - FHR4-based complement-activating multimeric immunotherapeutic complexes (COMIX) inhibit tumor growth of HER2-expressing xenografts in nude mice

AU - Devaux, Carole

AU - Etienne, Quentin

AU - Cohen, Jacques H. M.

AU - Dervillez, Xavier

N1 - Molecular Immunology Volume: 114 Issue number: Pages (from-to): 456-457 Article number: 124

PY - 2019/10

Y1 - 2019/10

UR - https://www.aminer.org/pub/5fc9ab75d83c7e914a9db928/fhr-based-complement-activating-multimeric-immunotherapeutic-complexes-comix-inhibit-tumor-growth-of

M3 - Abstract

SP - 456

EP - 457

T2 - 17th European Meeting on Complement in Human Disease (EMCHD)

Y2 - 14 September 2019 through 17 September 2019

ER -